Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
Lu-Lu Zhai,1,2,* Yang Wu,1,2,* Chong-Yang Cai,1,2 Zhi-Gang Tang1,2 1Department of General Surgery, Affiliated Provincial Hospital, Anhui Medical University, 2Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, People’s Republic of China *These authors contributed equa...
Main Authors: | Zhai LL, Wu Y, Cai CY, Tang ZG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | OncoTargets and Therapy |
Online Access: | https://www.dovepress.com/upregulated-matrix-metalloproteinase-2-and-downregulated-tissue-factor-peer-reviewed-article-OTT |
Similar Items
-
Association between expression of tissue inhibitors of metalloproteinases-1, matrix metalloproteinase-2, and matrix metalloproteinase-9 genes and axillary lymph nodes metastasis in patients with breast cancer
by: Alireza Abdollahi, et al.
Published: (2019-01-01) -
Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs)
by: Zhe Wang, et al.
Published: (2020-01-01) -
Upregulation of Arp2 expression is associated with the prognosis and prediction of lymph node metastasis in bladder urothelial carcinoma
by: Xu N, et al.
Published: (2018-03-01) -
Influencing factors of non-sentinel lymph node metastasis in breast cancer patients with 1~2 positive sentinel lymph nodes
by: MENG Lei, et al.
Published: (2020-06-01) -
The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
by: Roman Bandurski, et al.
Published: (2008-02-01)